Abstract
Background: Inflammatory Bowel Disease (IBD) is characterized by chronic intestinal inflammation with unknown etiology. Interleukin-10 Knockout (IL-10 KO) Mice are known to develop intestinal inflammation that resemble CD. We investigated if a human adipose-derived stem cells (h-ASCs) are capable to attenuated colon inflammation in IL-10 KO mice. Methods: h-ASCs were isolated from adipose tissues obtained from human donors. Colitis was induced in the mice by administration of piroxicam orally. Mice treated with intraperitoneal h-ASCs injection (5×105 cells) or normal saline as control after induction of colitis. All mice were euthanized 14 days after colitis. Histopathologic score and level of inflammation related cytokines were evaluated. Comparisons were made between h-ASCs treated or control non-treated IL-10 KO mice and wild type littermate. Results: The flow cytometry showed higher expression of CD105, CD73, CD90, CD44, however, hematopoietic stem cell markers such as CD45, CD34 and CD31 were not expressed in ADSC. Clinical score was lower in h-ASCs treated IL-10 KO mice than in control. Histopathologic assesment of large intestine showed lower inflammatory cells infiltration and less mucosal damage in h-ASCs treated mice than in control. Tissue score was lower in h-ASCs treated IL-10 KO mice than in control. The level of Monocyte chemoattractant protein-1 and Toll-like receptor 4 expression in the large intestine was lower and anti human IL-10 and anti mouse IL-4 in the serum was higher in h-ASCs treated mice. Conclusions: These findings suggested that administration of h-ASCs show beneficial effect on T-cell induced spontaneous colitis model and emerge a therapeutic option in inflammatory bowel disease.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
